Showing results (251-260 of 415) with videos related to

Sort By:
Pageof 42
Assay and Drug Development Technologies|January 15, 2010
Profiling the NIH Small Molecule Repository for compounds that generate H2O2 by redox cycling in reducing environmentsKarina M Soares, Nicole Blackmon, Tong Ying Shun, et al.
European Journal of Medicinal Chemistry|July 23, 2023
Metabolism-guided development of Ko143 analogs as ABCG2 inhibitorsJunjie Zhu, Saifei Lei, Jie Lu, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 21, 2019
Perfluorooctane Sulfonate (PFOS) Produces Dopaminergic Neuropathology in Caenorhabditis elegansShreesh Raj Sammi, Rachel M Foguth, Claudia Sofía Nieves, et al.
The Journal of Organic Chemistry|July 23, 2016
Total Synthesis and Biological Evaluation of Tubulysin AnaloguesRaffaele Colombo, Zhiyong Wang, Junyan Han, et al.
Archives of Toxicology|October 5, 2017
t-BuOOH induces ferroptosis in human and murine cell linesChristine Wenz, Dagmar Faust, Berenike Linz, et al.
Molecular Pharmacology|July 3, 2004
Discovery and characterization of novel small molecule inhibitors of human Cdc25B dual specificity phosphataseMarni Brisson, Theresa Nguyen, Andreas Vogt, et al.
Assay and Drug Development Technologies|August 14, 2008
Development of a 384-well colorimetric assay to quantify hydrogen peroxide generated by the redox cycling of compounds in the presence of reducing agentsPaul A Johnston, Karina M Soares, Sunita N Shinde, et al.
In Vivo (Athens, Greece)|May 18, 2011
Radiobiologic effects of GS-nitroxide (JP4-039) on the hematopoietic syndromeJulie P Goff, Michael W Epperly, Tracy Dixon, et al.
Pageof 42